2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·1 t sittenGood morning everyone 😀 what are the expectations for the stock in the coming week and where do you think we'll land next Friday at 5 PM ? 🤔
·15 min sittenI believe it will tip between 320-330 after the prescription numbers on Friday, which cumulatively are around 400,000 users of the pill - and investors understand that this pill really is a blockbuster. Quite logical actually. Relatively easy to get an online prescription for ordinary people with a slightly high BMI. And the price is quite affordable for many. Summer is approaching and many want the summer body. Many New Year's resolutions are starting to fail and more are dropping out of gyms. Then the pill is a simple alternative. Orforglipron won't come until April, which is unfortunately too late to lose the fat for the summer holiday. The Wegovy pill will dominate until summer and then a slight leveling off.
·9 t sittenUS aftermarket. It's already in minus again. The pattern is always the same - rises a couple of pct. and slowly trickles back.
·13 t sittenI have an incredible number of Zealand Pharma shares now… fluctuations of 2-5 % will be felt significantly in my wealth… so even though it takes a lot to get an experienced real estate investor and stock speculator excited - So I will keep an extra eye on Zealand Pharma for the next period of time 🥰- ·16 t sittenSo it has started to decline significantly.
·16 t sitten · MuokattuThe dollar exchange rate versus Novo's bottom line might be a topic that has come up before, but I'm drowning in the history here under Novo..... Well, but the USA is Novo's absolute cash cow, and a weaker dollar is a headwind for $ revenues, as these must be converted to DKK. So USD = less DKK value, while costs at home remain the same. Anyone here who has dug a bit deeper into the annual report and knows how much Novo has "hedged" their dollar exposure? Yes, because the scenario is quite simple: Trump wants a weaker dollar, the dollar's status will SOONER or later be taken over by BRICS (or other), and the dollar is also weakened by the unrest in the USA. So I wonder how long their hedges can support the margins before it becomes too problematic for the financials. Has anyone researched this extremely important parameter from an investor's perspective?
·11 t sittenI have speculated on the same myself, but surely their acquisitions, full production of pills in US etc. can also be settled in $, so certain cost bases follow the exchange rate. The reported revenue will however be lower. It would be interesting to know the dataset for how large a part of their cost base is located in US, but one probably has to await the next couple of quarterly reports to guess the impact. I fear it will take some time before the dollar goes up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 t sittenGood morning everyone 😀 what are the expectations for the stock in the coming week and where do you think we'll land next Friday at 5 PM ? 🤔·15 min sittenI believe it will tip between 320-330 after the prescription numbers on Friday, which cumulatively are around 400,000 users of the pill - and investors understand that this pill really is a blockbuster. Quite logical actually. Relatively easy to get an online prescription for ordinary people with a slightly high BMI. And the price is quite affordable for many. Summer is approaching and many want the summer body. Many New Year's resolutions are starting to fail and more are dropping out of gyms. Then the pill is a simple alternative. Orforglipron won't come until April, which is unfortunately too late to lose the fat for the summer holiday. The Wegovy pill will dominate until summer and then a slight leveling off.
- ·9 t sittenUS aftermarket. It's already in minus again. The pattern is always the same - rises a couple of pct. and slowly trickles back.
- ·13 t sittenI have an incredible number of Zealand Pharma shares now… fluctuations of 2-5 % will be felt significantly in my wealth… so even though it takes a lot to get an experienced real estate investor and stock speculator excited - So I will keep an extra eye on Zealand Pharma for the next period of time 🥰
- ·16 t sittenSo it has started to decline significantly.
- ·16 t sitten · MuokattuThe dollar exchange rate versus Novo's bottom line might be a topic that has come up before, but I'm drowning in the history here under Novo..... Well, but the USA is Novo's absolute cash cow, and a weaker dollar is a headwind for $ revenues, as these must be converted to DKK. So USD = less DKK value, while costs at home remain the same. Anyone here who has dug a bit deeper into the annual report and knows how much Novo has "hedged" their dollar exposure? Yes, because the scenario is quite simple: Trump wants a weaker dollar, the dollar's status will SOONER or later be taken over by BRICS (or other), and the dollar is also weakened by the unrest in the USA. So I wonder how long their hedges can support the margins before it becomes too problematic for the financials. Has anyone researched this extremely important parameter from an investor's perspective?·11 t sittenI have speculated on the same myself, but surely their acquisitions, full production of pills in US etc. can also be settled in $, so certain cost bases follow the exchange rate. The reported revenue will however be lower. It would be interesting to know the dataset for how large a part of their cost base is located in US, but one probably has to await the next couple of quarterly reports to guess the impact. I fear it will take some time before the dollar goes up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2025 Q4 -tulosraportti
9 päivää sitten
‧1 t 1 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 6.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 5.2. | ||
Ylimääräinen yhtiökokous 2025 14.11.2025 | ||
2025 Q3 -tulosraportti 6.11.2025 | ||
2025 Q2 -tulosraportti 7.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
7,95 DKK/osake
Irtoamispäivä 27.3.
3,80%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·1 t sittenGood morning everyone 😀 what are the expectations for the stock in the coming week and where do you think we'll land next Friday at 5 PM ? 🤔·15 min sittenI believe it will tip between 320-330 after the prescription numbers on Friday, which cumulatively are around 400,000 users of the pill - and investors understand that this pill really is a blockbuster. Quite logical actually. Relatively easy to get an online prescription for ordinary people with a slightly high BMI. And the price is quite affordable for many. Summer is approaching and many want the summer body. Many New Year's resolutions are starting to fail and more are dropping out of gyms. Then the pill is a simple alternative. Orforglipron won't come until April, which is unfortunately too late to lose the fat for the summer holiday. The Wegovy pill will dominate until summer and then a slight leveling off.
- ·9 t sittenUS aftermarket. It's already in minus again. The pattern is always the same - rises a couple of pct. and slowly trickles back.
- ·13 t sittenI have an incredible number of Zealand Pharma shares now… fluctuations of 2-5 % will be felt significantly in my wealth… so even though it takes a lot to get an experienced real estate investor and stock speculator excited - So I will keep an extra eye on Zealand Pharma for the next period of time 🥰
- ·16 t sittenSo it has started to decline significantly.
- ·16 t sitten · MuokattuThe dollar exchange rate versus Novo's bottom line might be a topic that has come up before, but I'm drowning in the history here under Novo..... Well, but the USA is Novo's absolute cash cow, and a weaker dollar is a headwind for $ revenues, as these must be converted to DKK. So USD = less DKK value, while costs at home remain the same. Anyone here who has dug a bit deeper into the annual report and knows how much Novo has "hedged" their dollar exposure? Yes, because the scenario is quite simple: Trump wants a weaker dollar, the dollar's status will SOONER or later be taken over by BRICS (or other), and the dollar is also weakened by the unrest in the USA. So I wonder how long their hedges can support the margins before it becomes too problematic for the financials. Has anyone researched this extremely important parameter from an investor's perspective?·11 t sittenI have speculated on the same myself, but surely their acquisitions, full production of pills in US etc. can also be settled in $, so certain cost bases follow the exchange rate. The reported revenue will however be lower. It would be interesting to know the dataset for how large a part of their cost base is located in US, but one probably has to await the next couple of quarterly reports to guess the impact. I fear it will take some time before the dollar goes up again.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
2 106 621
Myynti
Määrä
2 063 762
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 320 | - | - | ||
| 10 | - | - | ||
| 425 | - | - | ||
| 1 550 | - | - | ||
| 400 | - | - |
Ylin
314,85VWAP
Alin
308,5VaihtoMäärä
1 729,1 5 552 349
VWAP
Ylin
314,85Alin
308,5VaihtoMäärä
1 729,1 5 552 349
Välittäjätilasto
Dataa ei löytynyt